201 related articles for article (PubMed ID: 26930533)
21. SSRIs and SNRIs (SRI) in Pregnancy: Effects on the Course of Pregnancy and the Offspring: How Far Are We from Having All the Answers?
Ornoy A; Koren G
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31091646
[TBL] [Abstract][Full Text] [Related]
22. In utero exposure to selective serotonin reuptake inhibitors and risk for autism spectrum disorder.
Gidaya NB; Lee BK; Burstyn I; Yudell M; Mortensen EL; Newschaffer CJ
J Autism Dev Disord; 2014 Oct; 44(10):2558-67. PubMed ID: 24803368
[TBL] [Abstract][Full Text] [Related]
23. Prenatal exposure to antidepressants and depressed maternal mood alter trajectory of infant speech perception.
Weikum WM; Oberlander TF; Hensch TK; Werker JF
Proc Natl Acad Sci U S A; 2012 Oct; 109 Suppl 2(Suppl 2):17221-7. PubMed ID: 23045665
[TBL] [Abstract][Full Text] [Related]
24. Serotonin hypothesis of autism: implications for selective serotonin reuptake inhibitor use during pregnancy.
Harrington RA; Lee LC; Crum RM; Zimmerman AW; Hertz-Picciotto I
Autism Res; 2013 Jun; 6(3):149-68. PubMed ID: 23495208
[TBL] [Abstract][Full Text] [Related]
25. Visual, cognitive, and language assessments at 39 months: a follow-up study of children fed formulas containing long-chain polyunsaturated fatty acids to 1 year of age.
Auestad N; Scott DT; Janowsky JS; Jacobsen C; Carroll RE; Montalto MB; Halter R; Qiu W; Jacobs JR; Connor WE; Connor SL; Taylor JA; Neuringer M; Fitzgerald KM; Hall RT
Pediatrics; 2003 Sep; 112(3 Pt 1):e177-83. PubMed ID: 12949309
[TBL] [Abstract][Full Text] [Related]
26. Prenatal antidepressant exposures and gastrointestinal complaints in childhood: A gut-brain axis connection?
Salisbury AL; Papandonatos GD; Stroud LR; Smith AK; Brennan PA
Dev Psychobiol; 2020 Sep; 62(6):816-828. PubMed ID: 32167584
[TBL] [Abstract][Full Text] [Related]
27. Antidepressant use during pregnancy and childhood autism spectrum disorders.
Croen LA; Grether JK; Yoshida CK; Odouli R; Hendrick V
Arch Gen Psychiatry; 2011 Nov; 68(11):1104-12. PubMed ID: 21727247
[TBL] [Abstract][Full Text] [Related]
28. Identification of Modifiable Social and Behavioral Factors Associated With Childhood Cognitive Performance.
LeWinn KZ; Bush NR; Batra A; Tylavsky F; Rehkopf D
JAMA Pediatr; 2020 Nov; 174(11):1063-1072. PubMed ID: 32955555
[TBL] [Abstract][Full Text] [Related]
29. Sex-specific associations between maternal phthalate exposure and neurodevelopmental outcomes in children at 2 years of age in the APrON cohort.
Dewey D; Martin JW; MacDonald AM; Kinniburgh DW; Letourneau N; Giesbrecht GF; Field CJ; Bell RC; England-Mason G;
Neurotoxicology; 2023 Sep; 98():48-60. PubMed ID: 37517784
[TBL] [Abstract][Full Text] [Related]
30. Fine Motor Differences and Prenatal Serotonin Reuptake Inhibitors Exposure.
Partridge MC; Salisbury AL; LaGasse LL
J Pediatr; 2016 Aug; 175():144-149.e1. PubMed ID: 27215778
[TBL] [Abstract][Full Text] [Related]
31. The impact of prenatal serotonin reuptake inhibitor (SRI) antidepressant exposure and maternal mood on mother-infant interactions at 3 months of age.
Weikum WM; Mayes LC; Grunau RE; Brain U; Oberlander TF
Infant Behav Dev; 2013 Dec; 36(4):485-93. PubMed ID: 23728194
[TBL] [Abstract][Full Text] [Related]
32. Prenatal Antidepressant Exposure and Offspring Brain Morphologic Trajectory.
Koc D; Tiemeier H; Stricker BH; Muetzel RL; Hillegers M; El Marroun H
JAMA Psychiatry; 2023 Dec; 80(12):1208-1217. PubMed ID: 37647036
[TBL] [Abstract][Full Text] [Related]
33. Newborn neurobehavioral patterns are differentially related to prenatal maternal major depressive disorder and serotonin reuptake inhibitor treatment.
Salisbury AL; Wisner KL; Pearlstein T; Battle CL; Stroud L; Lester BM
Depress Anxiety; 2011 Nov; 28(11):1008-19. PubMed ID: 21898709
[TBL] [Abstract][Full Text] [Related]
34. Teacher-assessed behavior of children prenatally exposed to cocaine.
Delaney-Black V; Covington C; Templin T; Ager J; Nordstrom-Klee B; Martier S; Leddick L; Czerwinski RH; Sokol RJ
Pediatrics; 2000 Oct; 106(4):782-91. PubMed ID: 11015523
[TBL] [Abstract][Full Text] [Related]
35. Prenatal exposure to selective serotonin reuptake inhibitors and non-verbal cognitive functioning in childhood.
El Marroun H; White TJ; Fernandez G; Jaddoe VW; Verhulst FC; Stricker BH; Tiemeier H
J Psychopharmacol; 2017 Mar; 31(3):346-355. PubMed ID: 27624153
[TBL] [Abstract][Full Text] [Related]
36. Associations Between Brain Structure and Connectivity in Infants and Exposure to Selective Serotonin Reuptake Inhibitors During Pregnancy.
Lugo-Candelas C; Cha J; Hong S; Bastidas V; Weissman M; Fifer WP; Myers M; Talati A; Bansal R; Peterson BS; Monk C; Gingrich JA; Posner J
JAMA Pediatr; 2018 Jun; 172(6):525-533. PubMed ID: 29630692
[TBL] [Abstract][Full Text] [Related]
37. Neurobehavioral assessment of infants born at term and in utero exposure to serotonin reuptake inhibitors.
Smith MV; Sung A; Shah B; Mayes L; Klein DS; Yonkers KA
Early Hum Dev; 2013 Feb; 89(2):81-6. PubMed ID: 22999988
[TBL] [Abstract][Full Text] [Related]
38. Attention-deficit/hyperactivity disorder in children following prenatal exposure to antidepressants: results from the Norwegian mother, father and child cohort study.
Lupattelli A; Mahic M; Handal M; Ystrom E; Reichborn-Kjennerud T; Nordeng H
BJOG; 2021 Nov; 128(12):1917-1927. PubMed ID: 33982858
[TBL] [Abstract][Full Text] [Related]
39. In Utero Antidepressants and Neurodevelopmental Outcomes in Kindergarteners.
Singal D; Chateau D; Struck S; Lee JB; Dahl M; Derksen S; Katz LY; Ruth C; Hanlon-Dearman A; Brownell M
Pediatrics; 2020 May; 145(5):. PubMed ID: 32341177
[TBL] [Abstract][Full Text] [Related]
40. Prenatal Exposure to Folic Acid and Antidepressants and Language Development: A Population-Based Cohort Study.
Handal M; Skurtveit S; Roth C; Hernandez-Diaz S; Selmer R
J Clin Psychopharmacol; 2016 Aug; 36(4):333-9. PubMed ID: 27285658
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
